...
首页> 外文期刊>Dermatology: international journal for clinical and investigative dermatology >Cerebral and Cutaneous Involvements of Xanthoma Disseminatum Successfully Treated with an Interleukin-1 Receptor Antagonist: A Case Report and Minireview
【24h】

Cerebral and Cutaneous Involvements of Xanthoma Disseminatum Successfully Treated with an Interleukin-1 Receptor Antagonist: A Case Report and Minireview

机译:白介素1受体拮抗剂成功治疗了黄皮瘤的脑和皮肤侵袭:病例报告和Minireview。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A young male presented with panhypopituitarism (including diabetes insipidus) and temporal lobe epilepsy. A histology specimen of cutaneous papules was diagnostic of non Langerhans histiocytosis. The diagnosis of xanthoma granulomata was considered based on the clinical and brain MRI findings. Brain lesions significantly worsened over time despite radiotherapy until anakinra induced a complete clinical and radiological remission of all active lesions. Although a single case, the outcome of this patient with xanthoma disseminatum treated with an interleukin-1 receptor antagonist opens and strengthens new and recent physiopathogenic and treatment perspectives for the otherwise difficult to-treat non-Langerhans cell histiocytosis. Similar results with anakinra have been observed in patients with Erdheim-Chester disease and in multicentric reticulohistiocytosis. (C) 2016 S. Karger AG, Basel
机译:一名年轻男性,表现为全垂体功能减退(包括尿崩症)和颞叶癫痫。皮肤丘疹的组织学标本可诊断为非朗格汉斯组织细胞增多症。根据临床和脑部MRI的发现考虑诊断黄肉瘤肉芽肿。尽管放疗,脑部病变随时间推移仍显着恶化,直到anakinra诱导所有活动性病变的临床和放射学完全缓解。尽管只有一个病例,但该白介素1受体拮抗剂治疗的弥漫性黄瘤患者的结局打开并加强了新的和最近的生理病原学和治疗方法,以解决否则难以治疗的非朗格汉斯细胞组织细胞增生症。在Erdheim-Chester病患者和多中心网状组织细胞增生症患者中观察到了类似anakinra的结果。 (C)2016 S.Karger AG,巴塞尔

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号